JP2025522625A5 - - Google Patents

Info

Publication number
JP2025522625A5
JP2025522625A5 JP2024577361A JP2024577361A JP2025522625A5 JP 2025522625 A5 JP2025522625 A5 JP 2025522625A5 JP 2024577361 A JP2024577361 A JP 2024577361A JP 2024577361 A JP2024577361 A JP 2024577361A JP 2025522625 A5 JP2025522625 A5 JP 2025522625A5
Authority
JP
Japan
Prior art keywords
sso
slc25a13
sequence
overlaps
providing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024577361A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025522625A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SG2023/050458 external-priority patent/WO2024005715A1/en
Publication of JP2025522625A publication Critical patent/JP2025522625A/ja
Publication of JP2025522625A5 publication Critical patent/JP2025522625A5/ja
Pending legal-status Critical Current

Links

JP2024577361A 2022-06-28 2023-06-28 オリゴヌクレオチド Pending JP2025522625A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG10202250320V 2022-06-28
SG10202250320V 2022-06-28
PCT/SG2023/050458 WO2024005715A1 (en) 2022-06-28 2023-06-28 Oligonucleotides

Publications (2)

Publication Number Publication Date
JP2025522625A JP2025522625A (ja) 2025-07-15
JP2025522625A5 true JP2025522625A5 (https=) 2026-04-13

Family

ID=89384330

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024577361A Pending JP2025522625A (ja) 2022-06-28 2023-06-28 オリゴヌクレオチド

Country Status (4)

Country Link
US (1) US20250368991A1 (https=)
JP (1) JP2025522625A (https=)
CN (1) CN119948160A (https=)
WO (1) WO2024005715A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE070436T2 (hu) * 2017-10-23 2025-06-28 Stoke Therapeutics Inc Antiszensz oligomerek nonszensz-mediált RNS-lebomláson alapuló állapotok és betegségek kezelésére
EP4017979A4 (en) * 2019-08-19 2024-03-27 Stoke Therapeutics, Inc. COMPOSITIONS AND METHODS FOR MODULATING PROTEIN SPLICING AND EXPRESSION

Similar Documents

Publication Publication Date Title
JP7442574B2 (ja) Ｌｐａの遺伝子発現の阻害のための組成物及び方法
EP2636740B1 (en) Induction of exon skipping in eukaryotic cells
JP7049262B2 (ja) 結合組織成長因子を標的とするｒｎａ複合体を用いた特発性肺胞線維症の治療
JP2021533804A5 (https=)
JP2023537798A5 (https=)
JP2022545118A5 (https=)
CN101448945A (zh) 用于诱导外显子跳跃的手段和方法
JP2017516461A (ja) 遺伝子サイレンシングにおいて低下したｏｆｆ−ｔａｒｇｅｔ効果を有するｕｎａオリゴマー
JP2022533358A5 (https=)
JP2017519766A5 (https=)
JP2023539341A5 (https=)
JP2023521094A5 (https=)
JP2022520986A5 (https=)
JP7756166B2 (ja) Ｒｎａ治療薬及びその使用方法
JP2017510583A (ja) 遺伝子サイレンシング用トランスサイレチン対立遺伝子選択的ｕｎａオリゴマー
JP2024516183A5 (https=)
JPWO2005030960A1 (ja) ステイプル型オリゴヌクレオチドおよびそれからなる医薬
CN115702006A (zh) 缀合基团及其缀合物
JP2024543952A5 (https=)
JP2025522625A5 (https=)
JP2021513851A5 (https=)
KR101783444B1 (ko) miR-33-5p 를 이용한 뇌신경세포 보호 물질 스크리닝 방법
JP2024529930A5 (https=)
CN116670276A (zh) 用于通过多个靶标治疗疼痛的治疗组合物
JP2021527649A5 (https=)